Gait Disorders, NeurologicNCT00139321
Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian Syndromes
A study testing Force platform and electromyography in people with Gait Disorders, Neurologic, run by Groupe Hospitalier Pitie-Salpetriere at 1 site in France.
Trial summary
Gait disorders and falls are frequent in patients with parkinsonian syndromes. In patients with Parkinson's disease (PD), these signs occurred later during the course of the disease in comparison to patients with other degenerative parkinsonian disorders. Read more about this study
- Who is it for?
- Ages 18 to 85 yearsHealthy volunteers can take part
- Conditions the study is for
- Gait Disorders, Neurologic
- What is being tested?
- Force platform and electromyography
- Type of treatment
- Medical device
- How many people
- 110 participants
- Where
- 1 siteFrance
- Study dates
- Jun 2004to Jul 2007
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Patients able to walk without assistance
- Patients with Parkinson's disease or other degenerative parkinsonian syndromes (progressive supranuclear palsy [PSP], multiple system atrophy [MSA], corticobasal degeneration [CBD], etc.)
Who cannot join
- Other parkinsonian syndromes
- Dementia
- Neuroleptic treatment
Trial locations and contacts
1 site in 1 country.
France1 site
Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere
Paris, 75013
About this study
Gait disorders and falls are frequent in patients with parkinsonian syndromes. In patients with Parkinson's disease (PD), these signs occurred later during the course of the disease in comparison to patients with other degenerative parkinsonian disorders. The pathophysiology of these symptoms are still not fully understood. Gait initiation challenges the balance control system as the body moves from an upright stable static posture to a continuously unstable gait. The aim of this study is to analyse the gait initiation process in patients with parkinsonian disorders.
- Conditions
- Gait Disorders, Neurologic
- Being tested
- Force platform and electromyography
- Keywords
- Gait disorders, Postural instability, parkinsonian syndrome, Gait initiation, Parkinson's disease, Adults
- Medical subject headings
- Gait Disorders, Neurologic, Mobility Limitation, Parkinsonian Disorders, Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Force platform and electromyographyDevice
What is being measured
The primary outcome is the main question the study is designed to answer.
Biomechanical gait initiation parameters
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Aug 2005 (estimated)
- Study startJun 2004
- Primary completionJul 2007
- Study completionJul 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gait Disorders, NeurologicStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 110 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marie-laure Welter, Groupe Hospitalier Pitie-Salpetriere
- Investigators
- Yves Agid, MD, PhD, Study director, CIC-Pitié-Salpêtrière
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00139321
- Sponsor's protocol ID
- RBM0260
- Status last verified
- Jan 2013
- First submitted
- 30 Aug 2005
- Last updated
- 8 Jan 2013
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jan 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian Syndromes
- ClinicalTrials.gov ID
- NCT00139321
- Acronym / sponsor ID
- RBM0260
- Conditions
- Gait Disorders, Neurologic
- Keywords
- Gait disorders, Postural instability, parkinsonian syndrome, Gait initiation, Parkinson's disease, Adults
- Study type
- Interventional
- Recruitment status
- Terminated
- Enrolment
- 110 participants (estimated)
- Lead sponsor
- Groupe Hospitalier Pitie-SalpetriereUniversity, hospital or other
- Collaborators
- Institut National de la Santé Et de la Recherche Médicale, France
- Study start
- Jun 2004
- Primary completion
- Jul 2007 (actual)
- Study completion
- Jul 2007 (actual)
- First posted
- 31 Aug 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Gait disorders and falls are frequent in patients with parkinsonian syndromes. In patients with Parkinson's disease (PD), these signs occurred later during the course of the disease in comparison to patients with other degenerative parkinsonian disorders. The pathophysiology of these symptoms are still not fully understood. Gait initiation challenges the balance control system as the body moves from an upright stable static posture to a continuously unstable gait. The aim of this study is to analyse the gait initiation process in patients with parkinsonian disorders.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Patients able to walk without assistance
- Patients with Parkinson's disease or other degenerative parkinsonian syndromes (progressive supranuclear palsy [PSP], multiple system atrophy [MSA], corticobasal degeneration [CBD], etc.)
Key exclusion criteria (3 listed)
- Other parkinsonian syndromes
- Dementia
- Neuroleptic treatment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Force platform and electromyography | Device | – |
Primary outcome
Biomechanical gait initiation parameters
Results and safety
The study was stopped early. Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jan 2013.
Related trials for Gait Disorders, Neurologic
Recruiting
Interactive Intensive Gait Training in Walking Limitations
Neurologic Ambulation Disorder
RecruitingObservational study
Usability of the Smart Hallway System in Clinical Setting
Amputation, Gait Disorders, Neurologic
Active, not recruitingObservational study
Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project
Stroke, Acute, Gait, Hemiplegic
RecruitingObservational study
Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes
Gait Disorders, Neurologic, Atypical Parkinson Disease
Not yet recruitingObservational study
Gait Pattern and Its Relation to Cognition and VEP in Multiple Sclerosis
Multiple Sclerosis, Gait Disorders, Neurologic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yves Agid, MD, PhD study director
CIC-Pitié-Salpêtrière
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Force platform and electromyography in people with Gait Disorders, Neurologic, run by Groupe Hospitalier Pitie-Salpetriere at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 8 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early. Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Biomechanical gait initiation parameters. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2013; AzTrials last refreshed its copy on 8 Nov 2026.